Gaush Meditech Ltd

Research Gaush Meditech Ltd (2407.HK) on Bullrun: market cap HKD 621.13M, P/E 7.2. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is HKD 621.13M; P/E is 7.2.

Peer valuation comparison

Latest P/E is 7.24x versus a Healthcare sector median of 21.74x (66.7% below).

Latest P/E is 7.24x versus a China median of 16.26x (55.5% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CNY 1.38BCNY 96.19MCNY 110.47M45.9%0.66CNY 437.66MCNY 507.15MCNY 1.69B
FY2024CNY 1.43BCNY 92.39MCNY 26.57M46.4%0.63CNY 421.44MCNY 552.24MCNY 1.58B
FY2023CNY 1.41BCNY 173.52MCNY 203.44M49.2%1.17CNY 618.70MCNY 664.36MCNY 1.68B
FY2022CNY 1.25B-CNY 349.62MCNY 186.41M49.9%-3.61CNY 721.52MCNY 756.00MCNY 1.47B

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18HKD 621.13M7.2n/a0.3

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.3 HKD.

YearDividends/share
FY20250.3 CNY
FY20241.1 CNY

About Gaush Meditech Ltd

Gaush Meditech Ltd. engages in research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Gaush Meditech Ltd's market cap?

Gaush Meditech Ltd's market capitalization is HKD 621.13M.

What is Gaush Meditech Ltd's P/E ratio?

Gaush Meditech Ltd's price-to-earnings (P/E) ratio is 7.2.

What does Gaush Meditech Ltd do?

Gaush Meditech Ltd. engages in research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers.